Dr. Matthias Angelos Karajannis MD Pediatric Hematologist-Oncologist

Dr. Matthias Karajannis is a pediatric hematologist-oncologist in New York, New York and is affiliated with NYU Langone Medical Center. He received his medical degree from Freie University Berlin Faculty of Medicine and has been in practice for 11 years. Dr. Karajannis accepts several types of health insurance, listed below. He is one of 7 doctors at NYU Langone Medical Center who specialize in Pediatric Hematology-Oncology. He also speaks multiple languages, including French and German.

Are you Dr. Matthias Karajannis? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Pediatric Hematologist-Oncologist: General Pediatric Hematology & Oncology

Clinical Interests: Neuro-Oncology

Hospital Affiliation

NYU Langone Medical Center

Education & Medical Training

Duke University Hospital
Residency, Pediatrics, 1999 - 2002

Memorial Sloan-Kettering Cancer Center
Fellowship, Pediatric Hematology/Oncology, 2002 - 2005

Memorial Sloan-Kettering Cancer Center
Fellowship, Pediatric Neuro-Oncology, 2005 - 2006

New York Presbyterian Hospital
Fellowship, Pediatric Hematology/Oncology, 2002 - 2005

Freie University Berlin Faculty of Medicine
Class of 1997

Certifications & Licensure

American Board of Pediatrics
Certified 12 years in Pediatrics

American Board of Pediatrics
Certified 8 years in Pediatric Hematology-Oncology

NY State Medical License
Active through 2014

Publications & Presentations

Recurrent Ascites in a Patient With Low-grade Astrocytoma and Ventriculo-Peritoneal Shunt Treated With the Multikinase Inhibitor Sorafenib.
Legault, G.,Kieran, M. W.,Scott, R. M.,Chordas, C.,Milla, S. S.,Karajannis, M. A.

Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.
Hütt-Cabezas, M.,Karajannis, M. A.,Zagzag, D.,Shah, S.,Horkayne-Szakaly, I.,Rushing, E. J.,Cameron, J. D.,Jain, D.,Eberhart, C. G.,Raabe, E. H.,Rodriguez, F. J.

Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.
Hütt-Cabezas, M.,Karajannis, M. A.,Zagzag, D.,Shah, S.,Horkayne-Szakaly, I.,Rushing, E. J.,Cameron, J. D.,Jain, D.,Eberhart, C. G.,Raabe, E. H.,Rodriguez, F. J.

See all 24 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Illinois Blue Advantage HMO
  • BCBS Illinois HMO
  • BCBS Illinois PPO
  • BCBS North Carolina BlueOptions PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Coventry Health Care PPO Platinum
  • Empire BCBS HMO
  • Empire BCBS PPO
  • First Health PPO
  • GHI PPO
  • Great West PPO
  • Healthfirst New York
  • HealthLink PPO
  • HIP of New York - Select PPO
  • Humana ChoiceCare Network PPO
  • MagnaCare PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • MVP Healthcare PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.